arrow
M

Menno M. Schoonheim

amsterdam neuroscience
H指数:49
被引数:8,537

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The role of network connectivity and transcriptomic vulnerability in shaping gray matter atrophy in multiple sclerosis

网络连通性和转录组易损性在塑造多发性硬化症灰质萎缩中的作用

2026-11-110
OAAI
Survivor bias and disease progression in observational cohorts in multiple sclerosis

幸存者偏差和多发性硬化症观察性队列中的疾病进展

2026-10-140
PRE
The predictive value of serum neurofilament light chain levels beyond MRI measures for clinical and radiological disease progression in the earliest stages of multiple sclerosis

血清神经丝轻链水平对多发性硬化最早阶段临床和影像学疾病进展的预测价值,超越MRI测量

2026-09-090
OAAI
Decreased amyloid-related structure–function coupling in preclinical Alzheimer’s disease

阿尔茨海默病临床前期中淀粉样蛋白相关结构与功能耦合的减弱

2026-06-090
OAAI
Rethinking prognosis in multiple sclerosis: a multiaxial perspective

重新思考多发性硬化的预后:一种多轴视角

2026-05-190
PRE
Clinical and MRI substrates of Symbol Digit Modalities Test impairment in multiple sclerosis patients with an adult- and late-onset

多发性硬化成年及晚发型患者符号数字模式测试损伤的临床和MRI基础

2026-02-230
PRE
Non-inferiority of Rituximab versus OCrelizumab in Multiple Sclerosis (ROC-MS) – an Individual Participant Data Meta-Analysis

利妥昔单抗相较于奥瑞珠单抗在多发性硬化中的非劣效性(ROC-MS)——一项个体参与者数据meta分析

2025-11-110
OAAI
2024 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI for the diagnosis of multiple sclerosis

2024年MAGNIMS–CMSC–NAIMS关于MRI在多发性硬化症诊断中应用的共识建议

2025-09-170
PRE
Reliability of serum neurofilament light and glial fibrillary acidic protein for detecting disease activity upon discontinuation of first-line disease-modifying therapy in stable multiple sclerosis (DOT-MS)

血清神经丝蛋白轻链和胶质纤维酸性蛋白在稳定型多发性硬化(DOT-MS)中停用一线疾病修饰疗法后检测疾病活动的可靠性

2025-07-230
OAAI